‘Autoantibody-negative’ AIH occurs in 10–20% of AIH cases and is defined by the absence of ANA, ASMA, anti-LKM, and AMA antibodies at the time of presentation. This evidence concerns the gene BTG3 and autoimmune hepatitis.